Genetically engineering NK cells can destroy tumor-regenerating glioblastoma stem cells

By | June 18, 2021
Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing the TFG-β signaling protein, which blocks NK cell activity.